Summary of Purpose
Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous...Read More →
The following dates are available for this trial. Trial information last updated on 21 September 2017.
|1 Jan 2016||21 Sep 2017||1 Dec 2018||1 Dec 2018||1 Sep 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Benoit DAUBAIL, MD
email@example.com 3 80 29 37 53